Junbeom Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Junbeom Park has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Ji-Young Sul
Department of Surgery, Chungnam National University Hospital & Chungnam National University School of Medicine, Daejeon 35015, Republic of Korea
6 shared publications - Chaeyoun Oh
Department of Pediatric Surgery, Korea University Ansan Hospital, Korea University College of Medicine, Ansan 15355, Republic of Korea
3 shared publications - Eunyoung Jung
Division of Pediatric Surgery, Department of Surgery, Keimyung University Dongsan Hospital, Keimyung University School of Medicine, Daegu, Korea
3 shared publications - Hee-Beom Yang
Department of Pediatric Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
3 shared publications - Hyun-Young Kim
Department of Pediatric Surgery, Seoul National University Hospital, Seoul, Korea
3 shared publications - Jae Hee Chung
Department of Surgery, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
3 shared publications
Latest Publications
- 24 September 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (12)
Long-term outcomes of biliary atresia in Korea: A nationwide multicenter cohort study (2012–2021)
- 24 September 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (12)
Long-term outcomes of biliary atresia in Korea: A nationwide multicenter cohort study (2012–2021)
- 11 March 2026
- Published by Springer Nature in Hernia
- Vol. 30 (1) , 125
Prospective, randomized, controlled trial comparing self-gripping and conventional mesh in laparoscopic totally extra peritoneal inguinal hernia repair
- 11 March 2026
- Published by Springer Nature in Hernia
- Vol. 30 (1) , 125
Prospective, randomized, controlled trial comparing self-gripping and conventional mesh in laparoscopic totally extra peritoneal inguinal hernia repair
- 24 January 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (5) , 162948
A multicenter retrospective analysis by the Korean Association of Pediatric Surgeons comparing laparoscopic and open surgical repair of congenital duodenal obstruction
- 24 January 2026
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 61 (5) , 162948
A multicenter retrospective analysis by the Korean Association of Pediatric Surgeons comparing laparoscopic and open surgical repair of congenital duodenal obstruction
- Open Access
- 1 January 2025
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 108 (4) , 211-218
Nationwide big data analysis of inguinal hernia surgery trends in South Korea (2016–2022)
Ki H, et al. Ann Surg Treat Res. 2025 Apr;108(4):211-218. https://doi.org/10.4174/astr.2025.108.4.211
- 1 January 2025
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 108 (4) , 211-218
Open AccessNationwide big data analysis of inguinal hernia surgery trends in South Korea (2016–2022)
Ki H, et al. Ann Surg Treat Res. 2025 Apr;108(4):211-218. https://doi.org/10.4174/astr.2025.108.4.211
- Open Access
- 2 November 2022
- Published by XMLink in Pediatric Gastroenterology, Hepatology & Nutrition
- Vol. 25 (6) , 453-460
Postoperative Complications of Esophageal Atresia and Role of Endoscopic Balloon Dilatation in Anastomotic Strictures
Cho JY, et al. Pediatr Gastroenterol Hepatol Nutr. 2022 Nov;25(6):453-460. https://doi.org/10.5223/pghn.2022.25.6.453
- 2 November 2022
- Published by XMLink in Pediatric Gastroenterology, Hepatology & Nutrition
- Vol. 25 (6) , 453-460
Open AccessPostoperative Complications of Esophageal Atresia and Role of Endoscopic Balloon Dilatation in Anastomotic Strictures
Cho JY, et al. Pediatr Gastroenterol Hepatol Nutr. 2022 Nov;25(6):453-460. https://doi.org/10.5223/pghn.2022.25.6.453
- Open Access
Eribulin Mesylate Improves Cisplatin-Induced Cytotoxicity of Triple-Negative Breast Cancer by Extracellular Signal-Regulated Kinase 1/2 Activation
Background and Objectives; Triple-negative breast cancer (TNBC) is associated with poor patient prognosis because of its multiple molecular features. Thus, more effective treatment for TNBC is urgently needed. This study determined the possible involvement of ERK1/2 activation in cisplatin-induced cytotoxicity in TNBC by providing additional eribulin treatment. Materials and Methods; We investigated cell viability and apoptosis caused by eribulin, cisplatin, or co-treatment in HCC38, MDA-MB-231, and SKBR3 human breast cancer cells. Results; Cisplatin significantly lowered cell viability and caused high apoptotic cell death in all breast cancer cell lines. The viability of TNBC cells was significantly lower in the group co-treated with cisplatin and eribulin than in the cisplatin-only treatment group. Additional eribulin treatment significantly enhanced PARP cleavage and caspase-3 activity in cisplatin-treated TNBC cells. Moreover, cisplatin treatment activated ERK1/2 in all breast cancer cell lines. The cisplatin and eribulin combination synergistically activated ERK1/2 in TNBC cells compared with the cisplatin-only treatment. Administration of the ERK1/2 inhibitor PD98059 increased the viability of TNBC cells treated with cisplatin plus eribulin. Conclusions; Eribulin could synergize the cytotoxic and apoptotic activities of cisplatin and increase ERK1/2 activation, thus enhancing anti-cancer effects against TNBC cells.
Open AccessEribulin Mesylate Improves Cisplatin-Induced Cytotoxicity of Triple-Negative Breast Cancer by Extracellular Signal-Regulated Kinase 1/2 Activation
Background and Objectives; Triple-negative breast cancer (TNBC) is associated with poor patient prognosis because of its multiple molecular features. Thus, more effective treatment for TNBC is urgently needed. This study determined the possible involvement of ERK1/2 activation in cisplatin-induced cytotoxicity in TNBC by providing additional eribulin treatment. Materials and Methods; We investigated cell viability and apoptosis caused by eribulin, cisplatin, or co-treatment in HCC38, MDA-MB-231, and SKBR3 human breast cancer cells. Results; Cisplatin significantly lowered cell viability and caused high apoptotic cell death in all breast cancer cell lines. The viability of TNBC cells was significantly lower in the group co-treated with cisplatin and eribulin than in the cisplatin-only treatment group. Additional eribulin treatment significantly enhanced PARP cleavage and caspase-3 activity in cisplatin-treated TNBC cells. Moreover, cisplatin treatment activated ERK1/2 in all breast cancer cell lines. The cisplatin and eribulin combination synergistically activated ERK1/2 in TNBC cells compared with the cisplatin-only treatment. Administration of the ERK1/2 inhibitor PD98059 increased the viability of TNBC cells treated with cisplatin plus eribulin. Conclusions; Eribulin could synergize the cytotoxic and apoptotic activities of cisplatin and increase ERK1/2 activation, thus enhancing anti-cancer effects against TNBC cells.
- Open Access
- 1 January 2021
- Published by Korean Association of Pediatric Surgeons in Advances in Pediatric Surgery
- Vol. 27 (2) , 37-45
Open Inguinal Hernia Repair with Transinguinal Laparoscopic Examination in Children: A 13 Years of Experience
Ko M, et al. Adv Pediatr Surg. 2021 Dec;27(2):37-45. https://doi.org/10.13029/aps.2021.27.2.37
- 1 January 2021
- Published by Korean Association of Pediatric Surgeons in Advances in Pediatric Surgery
- Vol. 27 (2) , 37-45
Open AccessOpen Inguinal Hernia Repair with Transinguinal Laparoscopic Examination in Children: A 13 Years of Experience
Ko M, et al. Adv Pediatr Surg. 2021 Dec;27(2):37-45. https://doi.org/10.13029/aps.2021.27.2.37
- Open Access
- 1 January 2021
- Published by Korean Association of Thyroid and Endocrine Surgeons in Journal of Endocrine Surgery
- Vol. 21 (4) , 86-93
Effectiveness of Unilateral Adrenalectomy in Primary Hyperaldosteronism on Blood Pressure Regulation
- 1 January 2021
- Published by Korean Association of Thyroid and Endocrine Surgeons in Journal of Endocrine Surgery
- Vol. 21 (4) , 86-93
Open AccessEffectiveness of Unilateral Adrenalectomy in Primary Hyperaldosteronism on Blood Pressure Regulation
- Open Access
- 15 June 2020
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 23 (2) , 80-85
Umbilical Port Site Hernia and Diastasis Recti
The port site hernia (PSH) is a specific type of incisional hernia related to the trocar sites of laparoscopic surgery. Diastasis recti of the abdominis muscle (DR) is the separation of the rectus muscle by a certain distance. The present study aims to present our experience with umbilical PSH and concomitant DR and to raise awareness of DR as one of the risk factors of umbilical PSH. Eighteen patients with umbilical PSH after laparoscopic abdominal surgery, was retrospectively reviewed. Preoperative CT was analyzed to measure the Inter-recti distance (IRD) for all patients. Other factors, such as trocar size, wound infection, obesity (BMI), port extension, suture materials, and pre-existing co-morbidities, were recorded and analyzed. Extension of the port incision was associated with umbilical PSH. Ten out of eighteen umbilical PSH patients (56%) had DR before they had first laparoscopic surgery. Nine (50%) patients showed sarcopenia. Moreover, four out of five recurrences had DR. More than two recurrences were all associated with DR. Port extension and sarcopenia were risk factors of umbilical PSH. Also, DR might be a possible risk factor of umbilical PSH occurrence and recurrence. Surgeons should be aware of the presence of DR before the planning of the laparoscopic surgery by diagnostic imaging. If DR is associated with umbilical PSH, we need to consider the correction of both pathologies at the same time.
- 15 June 2020
- Published by The Korean Society of Endo-Laparoscopic & Robotic Surgery in Journal of Minimally Invasive Surgery
- Vol. 23 (2) , 80-85
Open AccessUmbilical Port Site Hernia and Diastasis Recti
The port site hernia (PSH) is a specific type of incisional hernia related to the trocar sites of laparoscopic surgery. Diastasis recti of the abdominis muscle (DR) is the separation of the rectus muscle by a certain distance. The present study aims to present our experience with umbilical PSH and concomitant DR and to raise awareness of DR as one of the risk factors of umbilical PSH. Eighteen patients with umbilical PSH after laparoscopic abdominal surgery, was retrospectively reviewed. Preoperative CT was analyzed to measure the Inter-recti distance (IRD) for all patients. Other factors, such as trocar size, wound infection, obesity (BMI), port extension, suture materials, and pre-existing co-morbidities, were recorded and analyzed. Extension of the port incision was associated with umbilical PSH. Ten out of eighteen umbilical PSH patients (56%) had DR before they had first laparoscopic surgery. Nine (50%) patients showed sarcopenia. Moreover, four out of five recurrences had DR. More than two recurrences were all associated with DR. Port extension and sarcopenia were risk factors of umbilical PSH. Also, DR might be a possible risk factor of umbilical PSH occurrence and recurrence. Surgeons should be aware of the presence of DR before the planning of the laparoscopic surgery by diagnostic imaging. If DR is associated with umbilical PSH, we need to consider the correction of both pathologies at the same time.